Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Fortune

Covid conspiracy theorist convicted of terrorism after Telegram calls for vaccine violence

Patrick Ruane, 55, from Paddington, west London, weaponised social media app Telegram to encourage attacks

Evening Standard

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

A New York City mural honoring ancient and modern figures in medicine could end up in pieces if it can’t find a new patron soon

The Independent UK

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart

Is Pfizer Stock Underperforming the Dow?

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.

Barchart

COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the COVID-19 vaccine. The Centers for Disease Control and Prevention quickly endorsed the new shot to protect against severe illness.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Fortune

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Times of India

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

The Independent UK

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Top News

Pfizer's Dividend Yield Surpasses 6% Mark, Attracting Investors

Learn about the role of dividends in stock market returns and the significance of sustainable yields, using Pfizer as an example.

The Independent UK

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

Barchart

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

LiveScience

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

The Independent UK

About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds

About half the U.S. state attorneys general have traveled to France for an event cosponsored by a group largely funded by companies

Barchart

Is Wall Street Bullish or Bearish on Pfizer Stock?

Pfizer has underperformed relative to the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s outlook.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

346 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.